Recent Advances in Pulmonary Hypertension Management.
SP, C., AL, M., S, R., & SH, V. (2026). Recent Advances in Pulmonary Hypertension Management.. Heart failure clinics. https://doi.org/10.1016/j.hfc.2026.02.011
SP C, AL M, S R, SH V. Recent Advances in Pulmonary Hypertension Management.. Heart failure clinics. 2026; doi: 10.1016/j.hfc.2026.02.011
SP C, AL M, S R, et al. Recent Advances in Pulmonary Hypertension Management.[J]. Heart failure clinics. 2026. DOI: 10.1016/j.hfc.2026.02.011.
@article{sp2026,
author = {Cohen SP and Miller AL and Rajpal S and Visovatti SH},
title = {Recent Advances in Pulmonary Hypertension Management.},
journal = {Heart failure clinics},
year = {2026},
doi = {10.1016/j.hfc.2026.02.011},
note = {PMID: 42309630},
}
TY - JOUR AU - Cohen SP AU - Miller AL AU - Rajpal S AU - Visovatti SH TI - Recent Advances in Pulmonary Hypertension Management. T2 - Heart failure clinics PY - 2026 DO - 10.1016/j.hfc.2026.02.011 AN - PMID:42309630 ER -
Significant progress has been made in the management of pulmonary hypertension (PH), and especially pulmonary arterial hypertnesion (PAH), over the last 3 decades. Recent advances in the diagnosis, risk stratification, and treatment of the disease have resulted in improved outcomes. However, patients with PAH continue to experience significant morbidity and mortality. Thus, continued research efforts are needed in order to develop risk stratification models and therapies that take into account more individualized patient-specific factors.